• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用现代影像学技术检测头颈部肿瘤放化疗后局部区域复发。

Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging.

机构信息

Department of Otolaryngology, Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

出版信息

Oral Oncol. 2009 Apr-May;45(4-5):386-93. doi: 10.1016/j.oraloncology.2008.10.015. Epub 2008 Dec 17.

DOI:10.1016/j.oraloncology.2008.10.015
PMID:19095487
Abstract

After radiotherapy with or without chemotherapy differentiation between residual and recurrent head and neck cancer and (chemo)radiation sequelae is often difficult. Currently, most physicians aggressively pursue potential recurrences, leading to a high rate of futile invasive diagnostic, e.g. examinations under general anaesthesia with taking of biopsies, and surgical procedures, e.g. planned neck dissections, and a waste of health care resources. Therefore, diagnostic techniques which reliably select patients who should undergo these procedures are warranted. Conventional imaging techniques are not reliable enough for this purpose. Potential imaging techniques to detect residual and recurrent locoregional disease after chemoradiation are (serial) CT or MRI and FDG-PET, eventually in combination with specific response criteria or scoring systems. Diffusion MRI and PET/CT may further improve these techniques. FDG-PET may help to select patients clinically suspected of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy under general anaesthesia. It is not yet clear whether FDG-PET can reliable avoid futile routine evaluation by examination under general anaesthesia in oral and oropharyngeal cancer and planned neck dissection when a residual mass persists in the neck after (chemo)radiation. The most reliable scoring criteria and the optimal time interval between completion of radiation and FDG-PET still has to be assessed.

摘要

在接受放化疗或不放化疗后,头颈部癌症的残留肿瘤和复发性肿瘤与(放化疗)后遗症之间的区分往往较为困难。目前,大多数医生积极追求潜在的复发,导致大量不必要的侵入性诊断,例如全身麻醉下进行活检,以及手术程序,例如计划的颈部解剖,浪费了医疗保健资源。因此,有必要采用可靠的诊断技术来选择需要进行这些程序的患者。传统的影像学技术在此方面并不可靠。用于检测放化疗后局部区域残留和复发性疾病的潜在影像学技术包括(连续)CT 或 MRI 和 FDG-PET,最终与特定的反应标准或评分系统相结合。扩散 MRI 和 PET/CT 可能会进一步改进这些技术。FDG-PET 可能有助于选择在接受放射治疗后临床怀疑患有喉癌的患者,以便在全身麻醉下进行直接喉镜检查。目前尚不清楚 FDG-PET 是否可以在(放化疗)后颈部残留肿块时,可靠地避免口腔和口咽癌中常规全身麻醉下评估以及计划的颈部解剖中不必要的常规评估。仍需评估最可靠的评分标准和 FDG-PET 之间的最佳时间间隔。

相似文献

1
Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging.使用现代影像学技术检测头颈部肿瘤放化疗后局部区域复发。
Oral Oncol. 2009 Apr-May;45(4-5):386-93. doi: 10.1016/j.oraloncology.2008.10.015. Epub 2008 Dec 17.
2
Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting.口腔和口咽癌:治疗后 FDG PET 联合对比增强 CT。
Radiographics. 2011 Mar-Apr;31(2):355-73. doi: 10.1148/rg.312095765.
3
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.放疗后 4-6 个月行体格检查与氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对比评估头颈部肿瘤残留。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e825-32. doi: 10.1016/j.ijrobp.2010.11.072. Epub 2011 Feb 6.
4
PET monitoring of therapy response in head and neck squamous cell carcinoma.正电子发射断层扫描(PET)对头颈部鳞状细胞癌治疗反应的监测
J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20.
5
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.评估 18F-FDG PET/CT 和 CT/MRI 与头颈部鳞状细胞癌挽救性手术患者的组织病理学相关性。
Ann Surg Oncol. 2011 Sep;18(9):2579-84. doi: 10.1245/s10434-011-1655-x. Epub 2011 Mar 16.
6
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.评估 18F-FDG PET/CT 和 CT/MRI 与喉、下咽和食管鳞状细胞癌患者行中央区颈部清扫术的组织病理学相关性。
Oral Oncol. 2013 May;49(5):449-53. doi: 10.1016/j.oraloncology.2012.12.007. Epub 2013 Jan 12.
7
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.手术或放疗后头颈癌的复发:2-脱氧-2-[F-18]氟-D-葡萄糖PET与MR成像诊断的前瞻性比较
Radiology. 1996 Jul;200(1):135-41. doi: 10.1148/radiology.200.1.8657901.
8
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.局部晚期头颈部鳞状细胞癌放化疗后氟脱氧葡萄糖正电子发射断层扫描(FDG-PET-CT)延迟反应评估。
Clin Radiol. 2012 Oct;67(10):966-75. doi: 10.1016/j.crad.2012.02.016. Epub 2012 May 15.
9
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.头颈部鳞状细胞癌放(化)疗后局部复发:FDG-PET/MRI 联合弥散加权序列的诊断性能。
Eur Radiol. 2018 Feb;28(2):651-663. doi: 10.1007/s00330-017-4999-1. Epub 2017 Aug 15.
10
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.18F-FDG PET与CT/MRI在口腔鳞状细胞癌中的应用:一项对124例患者进行组织学相关性分析的前瞻性研究
J Nucl Med. 2005 Jul;46(7):1136-43.

引用本文的文献

1
Integrated analysis of oral rinse-derived and plasma circulating tumour DNA for mutation profiling and outcome prediction with oral squamous cell carcinoma.口腔鳞状细胞癌漱口液来源的循环肿瘤DNA与血浆循环肿瘤DNA用于突变谱分析和预后预测的综合分析
NPJ Precis Oncol. 2025 Jun 13;9(1):183. doi: 10.1038/s41698-025-00976-9.
2
Comparison of Diffusion-Weighted MRI Using Single-Shot Echo-Planar Imaging and Split Acquisition of Fast Spin-Echo Signal Imaging, a Non-EPI Technique, in Tumors of the Head and Neck.使用单次激发回波平面成像和快速自旋回波信号成像(一种非回波平面成像技术)的扩散加权磁共振成像在头颈部肿瘤中的比较。
AJNR Am J Neuroradiol. 2025 Apr 2;46(4):774-783. doi: 10.3174/ajnr.A8529.
3
Diagnostic accuracy of NI-RADS for prediction of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
NI-RADS 对预测头颈部鳞状细胞癌的诊断准确性:系统评价和荟萃分析。
Radiol Med. 2024 Jan;129(1):70-79. doi: 10.1007/s11547-023-01742-2. Epub 2023 Oct 30.
4
Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者淋巴结复发的核心针活检的诊断性能。
Sci Rep. 2022 Feb 7;12(1):2048. doi: 10.1038/s41598-022-06102-0.
5
MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?头颈部癌放化疗后行 MRI 检查:何时为显示最大反应的最佳延迟期?
Eur Radiol. 2021 Dec;31(12):9273-9286. doi: 10.1007/s00330-021-07913-x. Epub 2021 May 19.
6
13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients.口腔拭子的13基因DNA甲基化分析:口腔癌患者随访中一种有前景的非侵入性工具。
J Clin Med. 2019 Dec 2;8(12):2107. doi: 10.3390/jcm8122107.
7
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?放射性治疗后,C-11 蛋氨酸 PET 是否可替代 18-F FDG-PET 来识别复发性喉癌?
Clin Otolaryngol. 2019 Mar;44(2):124-130. doi: 10.1111/coa.13242. Epub 2018 Nov 18.
8
MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.MRI 弥散加权成像在头颈部鳞癌治疗后检测中的应用:形态学 MRI 标准为何重要。
AJNR Am J Neuroradiol. 2018 Apr;39(4):748-755. doi: 10.3174/ajnr.A5548. Epub 2018 Feb 15.
9
The application of ultrasound in detecting lymph nodal recurrence in the treated neck of head and neck cancer patients.超声在检测头颈部癌症患者治疗后颈部淋巴结复发中的应用。
Sci Rep. 2017 Jun 21;7(1):3958. doi: 10.1038/s41598-017-04039-3.
10
Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.用于检测和定量头颈部癌患者血浆中循环肿瘤DNA的液滴数字PCR技术。
BMC Cancer. 2017 Jun 19;17(1):428. doi: 10.1186/s12885-017-3424-0.